Search Orphan Drug Designations and Approvals
-
Generic Name: | all-cis-docosa-4,7,10,13,16,19-hexaenoic acid |
---|---|
Date Designated: | 05/21/2014 |
Orphan Designation: | Treatment of retinitis pigmentosa |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Celavista Mitobiogenesis, S.L. Edi. SEDE, Parque Cien_fico Universidad UPV Leioa, Vizcaya 33156 Spain The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-